Claritev Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
11.9%projected annual EPS growth
Analyst Coverage
6analysts covering
FY EPS (est.)
$5.58next fiscal year
Monitoring Framework
Key Performance Indicators
Annual Contract Value (ACV) Bookings Quarterly44.1MTarget: 80000000 to 100000000
Total Revenue Quarterly244.7MTarget: 985000000 to 1000000000
Adjusted EBITDA Quarterly146.9MTarget: 605000000 to 615000000
Watch Items
- Antitrust Litigation and Price-Fixing AllegationsTrigger: Adverse rulings or material settlements in consolidated federal multi-district litigation or state attorney general lawsuits (e.g., Arizona AG complaint)Action: Re-evaluate the legal risk premium, adjust the cost of equity/WACC, and assess potential impacts on client retention among major health insurers.
- No Surprises Act (NSA) Regulatory ImpactTrigger: Changes in independent dispute resolution (IDR) rules or surprise billing arbitration volumesAction: Monitor analytics-based services revenue and adjust volume assumptions for claims repricing.
Research as of 19 Jun 2026